• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[舌下免疫疗法治疗变应性鼻炎的疗效及细胞因子在其治疗效果中的预测作用]

[The efficacy of sublingual immunotherapy for allergic rhinitis and the predictive role of cytokines in its therapeutic effect].

作者信息

Sun Z H, Gao Z H, Xue J M, Wang X S, Song M T

机构信息

Shanxi Medical University, Taiyuan, 030001, China.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Apr;33(4):332-336. doi: 10.13201/j.issn.1001-1781.2019.04.011.

DOI:10.13201/j.issn.1001-1781.2019.04.011
PMID:30970404
Abstract

The study aimed to investigate the efficacy of sublingual immunotherapy(SLIT) in treatment of adult allergic rhinitis, and to explore the predictive role of baseline serum cytokine levels in its therapeutic effect.Sixty patients with moderatesevere perennial AR sensitized with house dust mites were treated for 2 years. The SLIT group(n=30) were treated with standardized dust mite vaccine SLIT and conventional drugs, and the control group(n=30) were treated with placebo and conventional drugs. The combined symptom and medication score(CSMS) were compared between the two groups to evaluate the efficacy at baseline and 2 year endpoint. According to therapeutic effect, the SLIT group and the control group were divided into subgroups respectively, and the baseline IFN-γ and IL4, IL10, IL17 levels were compared between the effective group and the ineffective group in each group. The ROC curve was drawn to find the best predictive index and the best cut-off value was calculated. ①There was no significant difference between the SLIT group and the control group at baseline CSMS(>0.05). There was significant difference between the two groups at 2year endpoint CSMS(<0.05). ②In the SLIT group, there was no significant difference between the effective group and the ineffective group with the IFN-γ and IL17(>0.05). The IL4 level in the effective group was significantly higher than the ineffective group while the IL10 level was significantly lower(<0.05). In the control group, there were no significant differences in the levels of IFN-γ, IL4, IL10 and IL17 between the two subgroups(>0.05). ③Baseline IL4/IL10 has higher predictive value than IL4 and IL10 alone. The best cut-off value is 2.04, and the sensitivity and specificity of predictive value were 72.7% and 73.7% respectively. SLIT combined with conventional drug therapy is more effective than conventional drug therapy alone. IL4/IL10 has a better predictive role in SLIT effect than IL4 or IL10 alone. The higher the ratio, the better therapeutic effect is.

摘要

该研究旨在探讨舌下免疫疗法(SLIT)治疗成人变应性鼻炎的疗效,并探讨基线血清细胞因子水平对其治疗效果的预测作用。60例对屋尘螨致敏的中重度常年性变应性鼻炎患者接受了2年的治疗。SLIT组(n = 30)采用标准化尘螨疫苗SLIT和常规药物治疗,对照组(n = 30)采用安慰剂和常规药物治疗。比较两组的联合症状和用药评分(CSMS),以评估基线和2年终点时的疗效。根据治疗效果,将SLIT组和对照组分别分为亚组,比较每组有效组和无效组的基线IFN-γ以及IL4、IL10、IL17水平。绘制ROC曲线以找到最佳预测指标并计算最佳截断值。①SLIT组和对照组在基线CSMS时无显著差异(>0.05)。两组在2年终点CSMS时有显著差异(<0.05)。②在SLIT组中,有效组和无效组的IFN-γ和IL17无显著差异(>0.05)。有效组的IL4水平显著高于无效组,而IL10水平显著低于无效组(<0.05)。在对照组中,两个亚组之间的IFN-γ、IL4、IL10和IL17水平无显著差异(>0.05)。③基线IL4/IL10的预测价值高于单独的IL4和IL10。最佳截断值为2.04,预测价值的敏感性和特异性分别为72.7%和73.7%。SLIT联合常规药物治疗比单纯常规药物治疗更有效。IL4/IL10对SLIT效果的预测作用比单独的IL4或IL10更好。该比值越高,治疗效果越好。

相似文献

1
[The efficacy of sublingual immunotherapy for allergic rhinitis and the predictive role of cytokines in its therapeutic effect].[舌下免疫疗法治疗变应性鼻炎的疗效及细胞因子在其治疗效果中的预测作用]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Apr;33(4):332-336. doi: 10.13201/j.issn.1001-1781.2019.04.011.
2
[The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].[舌下特异性免疫疗法对儿童变应性鼻炎的疗效]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Apr 5;30(7):546-551. doi: 10.13201/j.issn.1001-1781.2016.07.010.
3
Enhanced Efficacy of Dust Mite Sublingual Immunotherapy in Low-Response Allergic Rhinitis Patients after Dose Increment at 6 Months: A Prospective Study.6个月剂量递增后尘螨舌下免疫疗法对低反应性变应性鼻炎患者疗效增强的前瞻性研究
Int Arch Allergy Immunol. 2020;181(4):311-319. doi: 10.1159/000505746. Epub 2020 Feb 18.
4
[Long-term clinical effect and safety observation of sublingual dermatophagoides farinae drop in preschool and school-age children with allergic rhinitis].[尘螨滴剂舌下含服治疗学龄前及学龄期儿童变应性鼻炎的长期临床疗效及安全性观察]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Mar 5;31(5):377-381. doi: 10.13201/j.issn.1001-1781.2017.05.012.
5
[Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in monosensitized and polysensitized patients with allergic rhinitis].[粉尘螨滴剂舌下免疫疗法对单致敏和多致敏变应性鼻炎患者的疗效]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Jul;48(7):549-54.
6
Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study.舌下尘螨免疫治疗单致敏和多致敏变应性鼻炎儿童的长期疗效:一项 7 年前瞻性研究。
Int Arch Allergy Immunol. 2019;180(2):144-149. doi: 10.1159/000500524. Epub 2019 Jun 28.
7
Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.舌下免疫治疗尘螨单致敏变应性鼻结膜炎儿童的双盲安慰剂对照随机试验。
Respir Med. 2013 Sep;107(9):1322-9. doi: 10.1016/j.rmed.2013.06.021. Epub 2013 Jul 23.
8
[Efficacy and economic evaluation of sublingual immunotherapy with Dermatophagoides farinae drops in patients with allergic rhinitis and allergic asthma].[粉尘螨滴剂舌下免疫治疗变应性鼻炎和变应性哮喘患者的疗效及经济学评价]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Apr 5;30(7):538-542. doi: 10.13201/j.issn.1001-1781.2016.07.008.
9
[Efficacy and safety of specific sublingual immunotherapy in children with allergic asthma and rhinitis].特异性舌下免疫疗法治疗儿童过敏性哮喘和鼻炎的疗效与安全性
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Feb 5;31(3):223-226. doi: 10.13201/j.issn.1001-1781.2017.03.014.
10
Clinical and cytokine responses to house dust mite sublingual immunotherapy.尘螨舌下免疫治疗的临床和细胞因子反应。
Ann Allergy Asthma Immunol. 2015 Apr;114(4):327-34. doi: 10.1016/j.anai.2014.12.015. Epub 2015 Feb 3.

引用本文的文献

1
Allergen immunotherapy in China.中国的变应原免疫疗法。
Front Allergy. 2024 Jan 8;4:1324844. doi: 10.3389/falgy.2023.1324844. eCollection 2023.